In a study in Science Advances, CHOP researchers describe a new algorithm that identifies mutations in the 98% of the human genome that does not code for genes.

More severely immunosuppressed children should avoid participation until the COVID-19 situation improves. Each child’s situation should be discussed with their doctor.

Within the Cancer Center at Children's Hospital of Philadelphia (CHOP), art therapy offers support to patients and families during hospitalization and treatment.

Denise Adams now leads the multidisciplinary team caring for children with vascular anomalies, identifying causes and treatments for these rare conditions.

Chelsea Keeler, MSW, LSW, discusses the growing field of psychosocial care for pediatric patients.

In a wide-ranging article about the increasing number of cancer survivors, a CHOP expert discusses endocrine late effects of treatment.

In a HemOnc Today article, a CHOP expert discusses the existing guidelines covering monitoring survivors for endocrine late effects of treatment.

The strategy, developed by CHOP researchers, would help generate a vaccine that would protect people across the population.

Jake Orlick, an 11-year-old boy, is fighting a courageous battle against Ewing Sarcoma, a rare form of bone cancer. Our Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, may be on the verge of a breakthrough with a novel new experimental treatment for relapsed Ewing sarcoma.

Patrick Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center of Childhood Cancer Research, is set to launch a novel, experimental approach to treating relapsed Ewing sarcoma, as highlighted in this story in the Philadelphia Inquirer.